BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261009
DTSTAMP:20260528T110955Z
CREATED:20260528T110955Z
LAST-MODIFIED:20260528T110955Z
UID:43630-1791158400-1791503999@www.pharmajournalist.com
SUMMARY:16th World Clinical Biomarkers & Companion Diagnostics Summit
DESCRIPTION:Fueled by surging digital pathology partnerships\, improved MRD sensitivity and high-plex single‑cell and multi‑omic profiling to breakthroughs\, the precision medicine field is evolving rapidly. \nBuilding on this momentum\, the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston this fall\, uniting 850+ senior stakeholders in the common goal of advancing timely\, accessible and affordable precision medicine to patients in need. \nBe the first to access our new event program: https://ter.li/5c0adwgh \nJoin industry-leading peers from biopharma\, diagnostics\, testing labs\, and regulatory bodies\, to unpack fit-for-purpose CDx strategies\, spark new co-development partnerships\, discover cutting-edge genomic sequencing\, pathology\, multi-omic\, single cell and multimodal innovations. \nThis year’s agenda will expand to five dedicated tracks of content to ensure your entire team leave equipped with the tools and insights to tackle the specific challenges facing them at their stage of development. \n\nBiomarker Discovery & Translation\nClinical & CDx Development\nRx-Dx Commercialization & Adoption\nDigital Pathology & Spatial Biomarkers (BRAND-NEW)\nMultimodal & AI‑Enabled Endpoints (BRAND-NEW)\n\nGrasp the opportunity to attend the industry’s leading touchpoint for drug-diagnostic co-development advancement. \nTogether let’s translate promising precision medicine into scalable\, equitable drug-diagnostic therapies for patients across oncology\, neurological\, autoimmune\, rare and chronic diseases. \nSign up today: https://ter.li/0jb66uvu \nRegistration is FREE* for drug developers and researchers.  \n*Subject to terms and conditions visit the website to learn more.
URL:http://www.pharmajournalist.com/event/16th-world-clinical-biomarkers-companion-diagnostics-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR